Empirical therapy and teicoplanin use in periprosthetic joint infecti

Empirical therapy and teicoplanin use in periprosthetic joint infecti

___

  • 1. Belmont PJ, Goodman GP, Rodriguez M, Bader JO, Waterman BR, Schoenfeld AJ. Predictors of hospital readmission following revision total knee arthroplasty. Knee Surg Sports Traumatol Arthrosc 2016; 24: 3329-3338.
  • 2. Osmon DR, Berbari EF, Berendt AR, Lew D, Zimmerli W, Steckelberg JM, Rao N, Hanssen A, Wilson WR; Infectious Diseases Society of America. Diagnosis and management of prosthetic joint infection: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis 2013; 56: e1-e25.
  • 3. Barrett L, Atkins B. The clinical presentation of prosthetic joint infection. J Antimicrob Chemother 2014; 69: i25-i27.
  • 4. Tornero E, García-Ramiro S, Martínez-Pastor JC, Bori G, Bosch J, Morata L, Sala M, Basora M, Mensa J, Soriano A. Prophylaxis with teicoplanin and cefuroxime reduces the rate of prosthetic joint infection after primary arthroplasty. Antimicrob Agents Chemother 2015; 59: 831-837.